Zobrazeno 1 - 10
of 14
pro vyhledávání: '"MESH: Antiphospholipid Syndrome"'
Autor:
Dongmei Yin, Katrien Devreese, Walid Chayoua, Gary W. Moore, Bas de Laat, Jacek Musiał, Hilde Kelchtermans, Jean-Christophe Gris, Stéphane Zuily, Philip G. de Groot
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (2), pp.463-478. ⟨10.1111/jth.14682⟩
Journal of Thrombosis and Haemostasis, 18(2), 463-478. Wiley
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (2), pp.463-478. ⟨10.1111/jth.14682⟩
Journal of Thrombosis and Haemostasis, 18(2), 463-478. Wiley
Background Classification of the antiphospholipid syndrome (APS) relies predominantly on detecting antiphospholipid antibodies (aPLs). Antibodies against a domain I (DI) epitope of anti-beta 2glycoprotein I (beta 2GPI) proved to be pathogenic, but ar
Autor:
Katrien Devreese, Jacek Musiał, Hilde Kelchtermans, Walid Chayoua, Jean-Christophe Gris, Gary W. Moore, Philip G. de Groot, Denis Wahl, Bas de Laat
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (1), pp.169-179. ⟨10.1111/jth.14633⟩
Journal of Thrombosis and Haemostasis, 18(1), 169-179. Wiley
Journal of Thrombosis and Haemostasis, Wiley, 2020, 18 (1), pp.169-179. ⟨10.1111/jth.14633⟩
Journal of Thrombosis and Haemostasis, 18(1), 169-179. Wiley
Background The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti-cardiolipin (aCL) and/or anti-beta 2glycoprotein I (a beta 2GPI) antibodies of th
Autor:
Sophie Renaud, Pascal Reboul, Hélène Perrochia, Maxime Teisseyre, Cedric Aglae, Olivier Moranne, S. Cariou
Publikováno v:
BMC Nephrology
BMC Nephrology, BioMed Central, 2020, 21, pp.196. ⟨10.1186/s12882-020-01856-z⟩
BMC Nephrology, Vol 21, Iss 1, Pp 1-3 (2020)
BMC Nephrology, BioMed Central, 2020, 21, pp.196. ⟨10.1186/s12882-020-01856-z⟩
BMC Nephrology, Vol 21, Iss 1, Pp 1-3 (2020)
Background The kidney is a major target in primary antiphospholipid syndrome. Several types of nephropathy have been reported, the most frequent being acute or chronic specific vascular nephropathies and membranous nephropathy. Case presentation A 59
Autor:
Sylvie Ripart, Sylvie Bouvier, Jean-Christophe Gris, Pascale Fabbro-Peray, Antonia Perez-Martin, E. Mousty, Vincent Letouzey, Eva Cochery-Nouvellon, Jonathan Broner
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2020, 105 (2), pp.490-497. ⟨10.3324/haematol.2018.213991⟩
Haematologica, Ferrata Storti Foundation, 2020, 105 (2), pp.490-497. ⟨10.3324/haematol.2018.213991⟩
International audience; Malignancies can be associated with positive antiphospholipid antibodies but the incidence of cancer among women with the purely obstetric form of antiphospholipid syndrome (APS) is currently unknown. Our aim was to investigat
Autor:
Francesca Gianniello, Denis Wahl, Pierre Fontana, Bas de Laat, Katrien Devreese, Hilde Kelchtermans, Stéphane Zuily, Jacek Musiał, Gary W. Moore, Jean-Christophe Gris, Walid Chayoua, Jasper A. Remijn, Rolf T. Urbanus
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2019, 119 (05), pp.797-806. ⟨10.1055/s-0039-1679901⟩
Thrombosis and Haemostasis, 119(5), 797-806. Georg Thieme Verlag
Thrombosis and Haemostasis, Vol. 119, No 05 (2019) pp. 797-806
Thrombosis and Haemostasis, Schattauer, 2019, 119 (05), pp.797-806. ⟨10.1055/s-0039-1679901⟩
Thrombosis and Haemostasis, 119(5), 797-806. Georg Thieme Verlag
Thrombosis and Haemostasis, Vol. 119, No 05 (2019) pp. 797-806
Background The anti-phospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with persistent presence of anti-phospholipid antibodies (aPL). Laboratory criteria include aPL detection by coagulation tests for lupus anticoa
Autor:
Neyraud, Vincent
Publikováno v:
Médecine humaine et pathologie. 2019
La maladie thromboembolique veineuse (MTEV) est une maladie grave et fréquente. L’enquête étiologique est primordiale en cas de MTEV idiopathique, particulièrement chez un patient âgé où la MTEV peut être la première manifestation d’un c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::b1d5df45afa8f0b9781eb3790a306a17
https://dumas.ccsd.cnrs.fr/dumas-03174939
https://dumas.ccsd.cnrs.fr/dumas-03174939
Publikováno v:
Lupus
Lupus, SAGE Publications, 2008, 17 (5), pp.431-6. ⟨10.1177/0961203308090030⟩
Lupus, SAGE Publications, 2008, 17 (5), pp.431-6. ⟨10.1177/0961203308090030⟩
There is increasing evidence that in systemic lupus erythematosus, nucleosomes, the basic chromatin component, represent both a driving immunogen and a major in vivo target for antibodies. Either a disturbed apoptosis or a reduced clearance of apopto
Publikováno v:
Pediatric Radiology
Pediatric Radiology, Springer Verlag, 2006, 36 (8), pp.870-3. ⟨10.1007/s00247-006-0183-5⟩
Pediatric Radiology, 2006, 36 (8), pp.870-3. ⟨10.1007/s00247-006-0183-5⟩
Pediatric Radiology, Springer Verlag, 2006, 36 (8), pp.870-3. ⟨10.1007/s00247-006-0183-5⟩
Pediatric Radiology, 2006, 36 (8), pp.870-3. ⟨10.1007/s00247-006-0183-5⟩
International audience; We report a rare example of catastrophic antiphospholipid syndrome (CAPS) in a young child. A 3-year-old girl with no previous medical history presented with extensive and recurrent thromboses. The diagnosis of CAPS was based
Autor:
Dekeyser, Manon, Zuily, Stéphane, Champigneulle, Jacqueline, Eschwège, Valérie, Frimat, Luc, Perret-Guillaume, Christine, Wahl, Denis
Publikováno v:
Néphrologie et Thérapeutique
Néphrologie et Thérapeutique, Elsevier Masson, 2014, 10 (1), pp.1-9. ⟨10.1016/j.nephro.2013.07.368⟩
Néphrologie et Thérapeutique, Elsevier Masson, 2014, 10 (1), pp.1-9. ⟨10.1016/j.nephro.2013.07.368⟩
International audience; The antiphospholipid syndrome is a thrombophilia characterized by the combination of arterial and/or venous thrombotic events or obstetric clinical events, associated with persistent presence of antiphospholipid antibodies. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50a7ce3b9df4a5e5f9e84359f556dbd8
https://hal.univ-lorraine.fr/hal-01791299
https://hal.univ-lorraine.fr/hal-01791299
Autor:
Gil , Helder, Magy , Nadine, Kleinclauss , François, Meaux-Ruault , Nadine, Bittard , Hugues, Dupond , Jean-Louis
Publikováno v:
Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2006, 24 (2), pp.217
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2006, 24 (2), pp.217
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f85b557eddaf494b6fcfbf2b627a0dc4
https://www.hal.inserm.fr/inserm-00473416
https://www.hal.inserm.fr/inserm-00473416